Connect your AI

Globus Medical GMED Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

Baxter InternationalBAX

-$152M-485%

Intuitive SurgicalISRG

——

SolventumSOLV

——

Other financials

Income statement

Revenue$759.9M+27.0%

Gross profit$525.8M+30.6%

Operating income$150.4M+55.0%

Net income$124.3M+64.7%

EPS (diluted)$0.90+66.7%

Balance sheet

Cash & equivalents$561.0M+21.6%

Total debt$116.3M+25.0%

Total equity$4.7B+15.8%

Total assets$5.4B+15.5%

Cash flow

Operating cash flow$202.4M+14.1%

CapEx$39.6M+9.7%

Free cash flow$162.7M+15.3%

Valuation

Market cap$10.76B+15.7%

Enterprise value$10.31B+15.6%

P/E18.3×-31.7×

P/S3.5×-0.2×

Profitability

Gross margin67.9%+7.3pp

Operating margin17.2%+7.0pp

Net margin18.9%+11.5pp

FCF margin19.7%-1.1pp

Returns & leverage

Return on equity13.3%+8.7pp

Debt / equity0×0.0×

Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Globus Medical's increase (decrease) in accounts receivable?: Globus Medical (GMED) reported increase (decrease) in accounts receivable of $13.4M in Q1 2026.
How has Globus Medical's increase (decrease) in accounts receivable changed year-over-year?: Globus Medical's increase (decrease) in accounts receivable increased by 159.3% year-over-year, from -$22.6M to $13.4M.